Scarica l'app Stockscreener
66.40
2.41%
-1.64
Dopo l'orario di chiusura:
66.40
Precedente Chiudi:
$68.04
Aprire:
$67.96
Volume 24 ore:
108.66K
Relative Volume:
1.43
Capitalizzazione di mercato:
$467.72M
Reddito:
-
Utile/perdita netta:
$-4.98M
Rapporto P/E:
-50.39
EPS:
-1.3177
Flusso di cassa netto:
$-3.85M
1 W Prestazione:
+8.13%
1M Prestazione:
+46.16%
6M Prestazione:
+107.44%
1 anno Prestazione:
+130.56%
Intervallo 1D:
$63.70
$70.19
Intervallo di 1 settimana:
$57.00
$70.23
Portata 52W:
$21.10
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Nome
Bright Minds Biosciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta DRUG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
66.40 | 484.65M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Iniziato | BTIG Research | Buy |
| 2025-05-13 | Iniziato | TD Cowen | Buy |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-23 | Iniziato | Piper Sandler | Overweight |
| 2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-26 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Published on: 2025-10-16 15:48:12 - newser.com
A activity2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Zacks Research - Defense World
Visualizing Bright Minds Biosciences Inc. stock with heatmapsJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Using data models to predict Bright Minds Biosciences Inc. stock movementJuly 2025 Pullbacks & Reliable Breakout Forecasts - newser.com
Bright Minds Biosciences Inc. (DRUG) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Will Bright Minds Biosciences Inc. stock outperform growth indexesSell Signal & Technical Pattern Recognition Alerts - newser.com
Using RSI to spot recovery in Bright Minds Biosciences Inc.Gap Up & Safe Swing Trade Setups - newser.com
Exit strategy if you’re trapped in Bright Minds Biosciences Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
Has Bright Minds Biosciences Inc. found a price floorGlobal Markets & Short-Term High Return Ideas - newser.com
Risk vs reward if holding onto Bright Minds Biosciences Inc.Weekly Profit Summary & AI Driven Stock Price Forecasts - newser.com
Will Bright Minds Biosciences Inc. outperform the marketInflation Watch & Weekly Top Stock Performers List - newser.com
Published on: 2025-10-13 07:44:40 - newser.com
Insiders Who Sold CA$17m Of Bright Minds Biosciences Made The Right Call - simplywall.st
Published on: 2025-10-10 09:53:23 - newser.com
How to use Fibonacci retracement on Bright Minds Biosciences Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
What technical models suggest about Bright Minds Biosciences Inc.’s comebackQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Regression analysis insights on Bright Minds Biosciences Inc. performanceMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
Published on: 2025-10-09 04:28:20 - newser.com
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives $81.00 Consensus Target Price from Analysts - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Stock Rating Lowered by Wall Street Zen - Defense World
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Rating of "Buy" from Analysts - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Cut to Sell at Wall Street Zen - MarketBeat
BTIG Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $72 - 富途牛牛
Published on: 2025-09-30 11:54:24 - earlytimes.in
What analysts say about Bright Minds Biosciences Inc stockResistance Zone Identification & High Return Investment Plans - earlytimes.in
Is Bright Minds Biosciences Inc a good long term investmentMarket Liquidity Analysis & Explosive Capital Growth Plans - earlytimes.in
What drives Bright Minds Biosciences Inc stock priceAI-Driven Market Analysis & Low Risk Investment Growth - earlytimes.in
Bright Minds Biosciences Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Fast Profit Stock Ideas - Early Times
H.C. Wainwright Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛
Goldman Sachs Group Inc. Takes Position in Bright Minds Biosciences Inc. $DRUG - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Rating Increased to Hold at Wall Street Zen - MarketBeat
Relative strength of Bright Minds Biosciences Inc. in sector analysisProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com
Using data filters to optimize entry into Bright Minds Biosciences Inc.July 2025 Gainers & Precise Buy Zone Identification - newser.com
Bright Minds Biosciences (NASDAQ:DRUG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Chart based analysis of Bright Minds Biosciences Inc. trendsEarnings Trend Report & High Accuracy Trade Alerts - newser.com
Portfolio Update: How is Bright Minds Biosciences Inc managing supply chain issues2025 Winners & Losers & Free High Return Stock Watch Alerts - khodrobank.com
How to forecast Bright Minds Biosciences Inc. trends using time seriesOptions Play & Fast Gain Stock Trading Tips - newser.com
What data driven models say about Bright Minds Biosciences Inc.’s futureMarket Performance Report & Verified Short-Term Trading Plans - newser.com
HC Wainwright Reaffirms "Buy" Rating for Bright Minds Biosciences (NASDAQ:DRUG) - MarketBeat
Aug Sectors: What is HIPOs 5 year growth outlookEarnings Performance Report & Technical Pattern Based Signals - khodrobank.com
Bright Minds Biosciences Inc Azioni (DRUG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):